Dark mode is part of the Premium plan.

It is included in the free trial.

Sign inSee Premium
Create a free account
Create a free account

Feeds › Lobbying

Lobbying

Who pays Washington lobbyists, how much, and on which issues.

About this data
What it is
Companies and trade groups that pay for lobbying must report it to Congress every quarter: who they hired, how much they spent, and which issues were lobbied.
Who files it
The lobbying firm, or the company itself when it uses its own staff, under the Lobbying Disclosure Act.
How current
Quarterly reports are due 20 days after each quarter ends, so they arrive in waves. We collect them daily.
Worth knowing
Amounts are rounded by the filer and cover the whole quarter. We match clients to listed companies automatically, so a few may be missed or misattributed.

All of this comes from public filings.

Source and freshness · Information, not investment advice (disclaimer).

Lobbying filings per day, last 30 days

05,00010.0K15.0KOct 17 · All filings: 629Oct 17 · Of listed companies: 127Oct 17Oct 18 · All filings: 1,044Oct 18 · Of listed companies: 159Oct 19 · All filings: 4,366Oct 19 · Of listed companies: 683Oct 20 · All filings: 10,242Oct 20 · Of listed companies: 1,907Oct 21 · All filings: 601Oct 21 · Of listed companies: 87Oct 21Oct 22 · All filings: 206Oct 22 · Of listed companies: 26Oct 23 · All filings: 114Oct 23 · Of listed companies: 5Oct 24 · All filings: 21Oct 24 · Of listed companies: 4Oct 25 · All filings: 12Oct 25 · Of listed companies: 4Oct 25Oct 26 · All filings: 119Oct 26 · Of listed companies: 8Oct 27 · All filings: 178Oct 27 · Of listed companies: 12Oct 28 · All filings: 66Oct 28 · Of listed companies: 3Oct 29 · All filings: 51Oct 29 · Of listed companies: 6Oct 29Oct 30 · All filings: 68Oct 30 · Of listed companies: 19Oct 31 · All filings: 8Oct 31 · Of listed companies: 0Nov 1 · All filings: 3Nov 1 · Of listed companies: 0Nov 2 · All filings: 58Nov 2 · Of listed companies: 5Nov 2Nov 3 · All filings: 346Nov 3 · Of listed companies: 21Nov 4 · All filings: 129Nov 4 · Of listed companies: 10Nov 5 · All filings: 96Nov 5 · Of listed companies: 5Nov 6 · All filings: 53Nov 6 · Of listed companies: 6Nov 6Nov 7 · All filings: 27Nov 7 · Of listed companies: 2Nov 8 · All filings: 21Nov 8 · Of listed companies: 0Nov 9 · All filings: 86Nov 9 · Of listed companies: 9Nov 10 · All filings: 102Nov 10 · Of listed companies: 9Nov 10Nov 11 · All filings: 78Nov 11 · Of listed companies: 6Nov 12 · All filings: 216Nov 12 · Of listed companies: 17Nov 13 · All filings: 170Nov 13 · Of listed companies: 16Nov 14 · All filings: 26Nov 14 · Of listed companies: 2Nov 14Nov 15 · All filings: 0Nov 15 · Of listed companies: 0
05,00010.0K15.0KOct 17 · All filings: 629Oct 17 · Of listed companies: 127Oct 17Oct 18 · All filings: 1,044Oct 18 · Of listed companies: 159Oct 19 · All filings: 4,366Oct 19 · Of listed companies: 683Oct 20 · All filings: 10,242Oct 20 · Of listed companies: 1,907Oct 21 · All filings: 601Oct 21 · Of listed companies: 87Oct 21Oct 22 · All filings: 206Oct 22 · Of listed companies: 26Oct 23 · All filings: 114Oct 23 · Of listed companies: 5Oct 24 · All filings: 21Oct 24 · Of listed companies: 4Oct 25 · All filings: 12Oct 25 · Of listed companies: 4Oct 25Oct 26 · All filings: 119Oct 26 · Of listed companies: 8Oct 27 · All filings: 178Oct 27 · Of listed companies: 12Oct 28 · All filings: 66Oct 28 · Of listed companies: 3Oct 29 · All filings: 51Oct 29 · Of listed companies: 6Oct 29Oct 30 · All filings: 68Oct 30 · Of listed companies: 19Oct 31 · All filings: 8Oct 31 · Of listed companies: 0Nov 1 · All filings: 3Nov 1 · Of listed companies: 0Nov 2 · All filings: 58Nov 2 · Of listed companies: 5Nov 2Nov 3 · All filings: 346Nov 3 · Of listed companies: 21Nov 4 · All filings: 129Nov 4 · Of listed companies: 10Nov 5 · All filings: 96Nov 5 · Of listed companies: 5Nov 6 · All filings: 53Nov 6 · Of listed companies: 6Nov 6Nov 7 · All filings: 27Nov 7 · Of listed companies: 2Nov 8 · All filings: 21Nov 8 · Of listed companies: 0Nov 9 · All filings: 86Nov 9 · Of listed companies: 9Nov 10 · All filings: 102Nov 10 · Of listed companies: 9Nov 10Nov 11 · All filings: 78Nov 11 · Of listed companies: 6Nov 12 · All filings: 216Nov 12 · Of listed companies: 17Nov 13 · All filings: 170Nov 13 · Of listed companies: 16Nov 14 · All filings: 26Nov 14 · Of listed companies: 2Nov 14Nov 15 · All filings: 0Nov 15 · Of listed companies: 0

All filings Of listed companies

Quarterly reports are due 20 days after each quarter ends, so filings come in waves.

Latest lobbying filings

Reset

Showing: ticker REGN

Latest lobbying filings
PostedClientLobbying firmReportAmountWhen a company hires a lobbying firm, the firm reports the income it received. When the company lobbies with its own staff, it reports its expenses instead.IssuesFiling
Nov 3, 2026REGN
Regeneron Pharmaceuticals, Inc.
Crane Strategies2026 third quarter$50.0KBUDLDA ↗
Oct 21, 2026REGN
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc2026 third quarter$590.0KCPT, TRD, TAX, HCRLDA ↗
Oct 20, 2026REGN
Regeneron Pharmaceuticals, Inc.
BGR Government Affairs2026 third quarter$90.0KHCRLDA ↗
Oct 19, 2026REGN
Regeneron Pharmaceuticals, Inc.
Arnold & Porter Kaye Scholer LLP2026 third quarter$10.0KHCRLDA ↗
Oct 16, 2026REGN
Regeneron Pharmaceuticals, Inc.
Checkmate Government Relations2026 third quarter$90.0KHCRLDA ↗
Oct 15, 2026REGN
Regeneron Pharmaceuticals, Inc.
The Washington Tax & Public Policy Group2026 third quarter$30.0KTAXLDA ↗
Aug 3, 2026REGN
Regeneron Pharmaceuticals, Inc.
Crane Strategies2026 second quarter$50.0KBUDLDA ↗
Jul 21, 2026REGN
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc2026 second quarter$630.0KHCR, MMM, CPT, TRDLDA ↗
Jul 20, 2026REGN
Regeneron Pharmaceuticals, Inc.
Arnold & Porter Kaye Scholer LLP2026 second quarter$50.0KHCRLDA ↗
Jul 20, 2026REGN
Regeneron Pharmaceuticals, Inc.
BGR Government Affairs2026 second quarter$90.0KHCRLDA ↗
Jul 15, 2026REGN
Regeneron Pharmaceuticals, Inc.
Checkmate Government Relations2026 second quarter$90.0KHCRLDA ↗
Jul 8, 2026REGN
Regeneron Pharmaceuticals, Inc.
The Washington Tax & Public Policy Group2026 second quarter$30.0KTAXLDA ↗
May 4, 2026REGN
Regeneron Pharmaceuticals, Inc.
Crane Strategies2026 first quarter$50.0KBUDLDA ↗
Apr 21, 2026REGN
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc2026 first quarter$640.0KHCR, MMM, CPT, TRDLDA ↗
Apr 20, 2026REGN
Regeneron Pharmaceuticals, Inc.
BGR Government Affairs2026 first quarter$90.0KHCRLDA ↗
Apr 20, 2026REGN
Regeneron Pharmaceuticals, Inc.
Arnold & Porter Kaye Scholer LLP2026 first quarter—BUD, HCRLDA ↗
Apr 15, 2026REGN
Regeneron Pharmaceuticals, Inc.
Checkmate Government Relations2026 first quarter$90.0KHCRLDA ↗
Apr 1, 2026REGN
Regeneron Pharmaceuticals, Inc.
The Washington Tax & Public Policy Group2026 first quarter$30.0KTAXLDA ↗
Jan 21, 2026REGN
Regeneron Pharmaceuticals, Inc.
Crane Strategies2025 fourth quarter$50.0KBUDLDA ↗
Jan 21, 2026REGN
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc2025 fourth quarter$610.0KTAX, HCR, MMM, CPTLDA ↗
Jan 20, 2026REGN
Regeneron Pharmaceuticals, Inc.
BGR Government Affairs2025 fourth quarter$90.0KHCRLDA ↗
Jan 20, 2026REGN
Regeneron Pharmaceuticals, Inc.
Checkmate Government Relations2025 fourth quarter$90.0KHCRLDA ↗
Jan 16, 2026REGN
Regeneron Pharmaceuticals, Inc.
Arnold & Porter Kaye Scholer LLP2025 fourth quarter—LDA ↗
Jan 16, 2026REGN
Regeneron Pharmaceuticals, Inc.
The Washington Tax & Public Policy Group2025 fourth quarter$30.0KTAXLDA ↗
Oct 20, 2025REGN
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc2025 third quarter$570.0KTRD, TAX, HCR, MMMLDA ↗
Oct 20, 2025REGN
Regeneron Pharmaceuticals, Inc.
BGR Government Affairs2025 third quarter$90.0KHCRLDA ↗
Oct 20, 2025REGN
Regeneron Pharmaceuticals, Inc.
Checkmate Government Relations2025 third quarter$90.0KHCRLDA ↗
Oct 16, 2025REGN
Regeneron Pharmaceuticals, Inc.
Arnold & Porter Kaye Scholer LLP2025 third quarter—LDA ↗
Oct 14, 2025REGN
Regeneron Pharmaceuticals, Inc.
The Washington Tax & Public Policy Group2025 third quarter$30.0KTAXLDA ↗
Oct 1, 2025REGN
Regeneron Pharmaceuticals, Inc.
Crane Strategies2025 third quarter$50.0KBUDLDA ↗
Jul 21, 2025REGN
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc2025 second quarter$610.0KHCR, MMM, CPT, TRDLDA ↗
Jul 21, 2025REGN
Regeneron Pharmaceuticals, Inc.
BGR Government Affairs2025 second quarter$90.0KHCRLDA ↗
Jul 20, 2025REGN
Regeneron Pharmaceuticals, Inc.
Checkmate Government Relations2025 second quarter$90.0KHCRLDA ↗
Jul 17, 2025REGN
Regeneron Pharmaceuticals, Inc.
Arnold & Porter Kaye Scholer LLP2025 second quarter—LDA ↗
Jul 11, 2025REGN
Regeneron Pharmaceuticals, Inc.
The Washington Tax & Public Policy Group2025 second quarter$30.0KTAXLDA ↗
Jul 10, 2025REGN
Regeneron Pharmaceuticals, Inc.
BGR Government Affairs2025 second quarter—HCRLDA ↗
Jul 1, 2025REGN
Regeneron Pharmaceuticals, Inc.
Crane Strategies2025 second quarter$50.0KBUDLDA ↗
May 5, 2025REGN
Regeneron Pharmaceuticals, Inc.
Crane Strategies2025 first quarter$50.0KBUDLDA ↗
Apr 21, 2025REGN
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc2025 first quarter$400.0KTAX, HCR, MMM, CPTLDA ↗
Apr 21, 2025REGN
Regeneron Pharmaceuticals, Inc.
Checkmate Government Relations2025 first quarter$30.0KHCRLDA ↗
Apr 21, 2025REGN
Regeneron Pharmaceuticals, Inc.
Arnold & Porter Kaye Scholer LLP2025 first quarter—LDA ↗
Apr 21, 2025REGN
Regeneron Pharmaceuticals, Inc.
Stewart Strategies and Solutions, LLC2024 fourth quarter$60.0KLDA ↗
Apr 17, 2025REGN
Regeneron Pharmaceuticals, Inc.
The Washington Tax & Public Policy Group2025 first quarter$30.0KTAXLDA ↗
Mar 27, 2025REGN
Regeneron Pharmaceuticals, Inc.
Checkmate Government Relations2025 first quarter—HCRLDA ↗
Feb 7, 2025REGN
Regeneron Pharmaceuticals, Inc.
The Washington Tax & Public Policy Group2025 first quarter—TAXLDA ↗
Jan 22, 2025REGN
Regeneron Pharmaceuticals, Inc.
Stewart Strategies and Solutions, LLC2024 fourth quarter$60.0KLDA ↗
Jan 21, 2025REGN
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc2024 fourth quarter$400.0KHCR, MMM, CPTLDA ↗
Jan 17, 2025REGN
Regeneron Pharmaceuticals, Inc.
Arnold & Porter Kaye Scholer LLP2024 fourth quarter—LDA ↗
Jan 7, 2025REGN
Regeneron Pharmaceuticals, Inc.
Crane Strategies2024 fourth quarter$50.0KBUDLDA ↗

49 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:20 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances